Supriya Lifescience Limited (SUPRIYA) — Financial Flexibility Index
Supriya Lifescience Limited (SUPRIYA) has a Financial Flexibility Index of 0.81x as of September 2025. Free cash flow of Rs978.14 Million (operating CF Rs555.65 Million minus capex Rs422.49 Million) represents 1% of total liabilities (Rs1.21 Billion). Check Supriya Lifescience Limited (SUPRIYA) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Supriya Lifescience Limited Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Supriya Lifescience Limited across 8 annual periods. See Supriya Lifescience Limited current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Supriya Lifescience Limited (2018–2025)
Year-by-year free cash flow to debt coverage for Supriya Lifescience Limited. For the full company profile including market capitalisation, see SUPRIYA market cap overview.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.90x | Rs3.35 Billion | Rs1.73 Billion | Rs1.16 Billion | ▲ +18.5% |
| 2024 | 2.45x | Rs2.59 Billion | Rs1.13 Billion | Rs1.06 Billion | ▲ +69.3% |
| 2023 | 1.45x | Rs1.75 Billion | Rs661.87 Million | Rs1.21 Billion | ▲ +58.3% |
| 2022 | 0.91x | Rs1.09 Billion | Rs488.01 Million | Rs1.19 Billion | ▲ +26.0% |
| 2021 | 0.72x | Rs1.28 Billion | Rs799.30 Million | Rs1.77 Billion | ▼ -3.5% |
| 2020 | 0.75x | Rs1.41 Billion | Rs1.16 Billion | Rs1.87 Billion | ▲ +115.0% |
| 2019 | 0.35x | Rs556.17 Million | Rs486.72 Million | Rs1.59 Billion | ▲ +197.6% |
| 2018 | 0.12x | Rs223.82 Million | Rs174.52 Million | Rs1.91 Billion | — |